Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
about
Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoformsProcessing of natural and recombinant CXCR3-targeting chemokines and implications for biological activityThe Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity.
P2860
Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Limited and defined truncation ...... nd recombinant NAP-2 variants.
@en
type
label
Limited and defined truncation ...... nd recombinant NAP-2 variants.
@en
prefLabel
Limited and defined truncation ...... nd recombinant NAP-2 variants.
@en
P2093
P2860
P356
P1476
Limited and defined truncation ...... nd recombinant NAP-2 variants.
@en
P2093
P2860
P304
P356
10.1074/JBC.270.11.6338
P407
P577
1995-03-01T00:00:00Z